Revelation Biosciences, Inc. announced the retirement of George F. Tidmarsh, MD, PhD, from its Board of Directors. Dr. Tidmarsh's departure is attributed to a potential conflict of interest arising from his new endeavor. He will be working closely with US governmental agencies in his capacity as Adjunct Professor of Pediatrics and Neonatology at Stanford University School of Medicine.
The company and Dr. Tidmarsh mutually agreed that his retirement was the best course of action to avoid any appearance of a conflict of interest. CEO James Rolke thanked Dr. Tidmarsh for his five years of guidance and support, wishing him success in his new projects. Dr. Tidmarsh also expressed his appreciation for the Revelation team's dedication.
Dr. Tidmarsh's new role involves significant interaction with governmental agencies, which could create perceived conflicts with his position on a clinical-stage biopharmaceutical company's board. This change in board composition is a notable event in the company's corporate governance structure.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.